IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Supriya Lifescience Limited is an Pharmaceutical based company, located in Mumbai, Supriya Lifescience Limited IPO size was 700.00 Cr. and was issued at 274.00 per share. The share of Supriya Lifescience Limited were listed at 390.35 per share and are currently trading at 745.45 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr
Sangli
business of global digital and technology services with artificial intelligence.
Mumbai
Supriya Lifescience operates in Pharmaceutical and Manufacturers And Suppliers Of Active Pharmaceuticals. The Issue is listed on BSE,NSE in Dec, 2021. Supriya Lifescience IPO size was 700.00 Cr. with Issue price of 274.00 .
Merchant Banker(s) of Supriya Lifescience IPO: Axis Capital Limited , ICICI Securities Limited
Supriya Lifescience IPO subscription was 71.51 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Supriya Lifescience IPO listed at a listing price of 390.35 against the offer price of 274.00.
The current market price of Supriya Lifescience is 745.45.
Why Us?
